GERN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: GERN Market Cap History GERN YTD Return |
GERN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: GERN Market Cap History GERN YTD Return |
GERN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+12.64% CAGR Mouse over chart for data details
|
GERN Stock Price Chart |
About Geron Corp. |
Geron is a biopharmaceutical company that is focused on the development and commercialization of imetelstat, a telomerase inhibitor. Co. is conducting two ongoing Phase 3 clinical trials that are designed to enable registration of imetelstat: (i) IMerge Phase 3 in lower risk myelodysplastic syndromes (MDS), and (ii) IMpactMF in refractory myelofibrosis (MF). Imetelstat has been granted Fast Track designations by the U.S. Food and Drug Administration for the treatment of patients with transfusion-dependent anemia due to lower risk MDS and who are refractory or resistant to treatment with an erythropoiesis stimulating agent and for the treatment of patients with MF. We show 56 historical shares outstanding datapoints in our coverage of GERN's shares outstanding history. Understanding the changing numbers of GERN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GERN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GERN by allowing them to research GERN shares outstanding history as well as any other stock in our coverage universe. |
GERN Current Stock Quote |
Free GERN Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
GERN Share Performance |
Shares Outstanding Peers |
Geron (GERN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
GFOR Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.